Sector consensus Terumo Corporation
Equities
4543
JP3546800008
Medical Equipment, Supplies & Distribution
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,057.00 JPY | +4.13% |
|
-2.46% | -9.34% |
| 25/02 | Galderma Announces Triple Approval of New Restylane Syringe in the EU, the U.S., and Canada | CI |
| 13/02 | Terumo Corporation, Q3 2026 Earnings Call, Feb 13, 2026 |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | JP¥2,956.15 | +52.22% | 13 | ||||||
| $133.39 | +17.94% | 25 | ||||||
| $111.69 | +16.83% | 26 | ||||||
| $408.46 | +10.94% | 13 | ||||||
| JP¥27,386.67 | -0.1% | 15 | ||||||
| $197.15 | +14.97% | 13 | ||||||
| $85.85 | +17.76% | 26 | ||||||
| $281.25 | +15.71% | 8 | ||||||
| €236.43 | +35.3% | 14 | ||||||
| $102.65 | +7.21% | 23 | ||||||
| $318.36 | +27.94% | 14 | ||||||
| $354.4 | +45.91% | 25 | ||||||
| NZ$41.12 | +0.94% | 12 | ||||||
| $200.67 | +10.16% | 15 | ||||||
| $109.54 | +21.09% | 13 | ||||||
| $90.17 | +28.08% | 12 | ||||||
| $21.63 | +13.68% | 15 | ||||||
| $324 | +13.81% | 5 | ||||||
| $186.28 | +48.03% | 18 | ||||||
| Average | 1,765.57 | +20.97% | 16 | ||||||
| Weighted average by Cap. | 2,565.17 | +17.20% | 20 |
- Stock Market
- Equities
- 4543 Stock
- Sector Terumo Corporation
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition